OncoPro Tumor Mutation Burden (TMB) Test
Understanding Tumor Mutation Burden Testing
The OncoPro Tumor Mutation Burden (TMB) Test represents a revolutionary advancement in cancer diagnostics, providing critical insights into the genetic complexity of tumors. This sophisticated molecular analysis quantifies the total number of somatic mutations within a tumor’s genome, offering valuable predictive information about potential response to immunotherapy treatments.
What is Tumor Mutation Burden?
Tumor Mutation Burden refers to the total number of mutations found in the DNA of cancer cells. Tumors with high TMB typically have more neoantigens – abnormal proteins that can be recognized by the immune system. This makes them more likely to respond to immunotherapies that help the immune system identify and attack cancer cells.
What the Test Measures and Detects
The OncoPro TMB Test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze tumor DNA and identify:
- Total somatic mutation count across the genome
- Mutation rate per megabase of DNA
- Specific mutation patterns and signatures
- Potential neoantigen formation
- Genetic markers predictive of immunotherapy response
Who Should Consider This Test
The OncoPro TMB Test is particularly beneficial for patients with:
- Advanced or metastatic cancers considering immunotherapy
- Cancers with unclear treatment pathways
- Tumors that have progressed on conventional therapies
- Rare cancer types where standard biomarkers are unavailable
- Patients seeking personalized treatment options
Clinical Indications
This test is especially valuable for patients experiencing:
- Treatment-resistant cancers
- Recurrent disease progression
- Limited response to traditional chemotherapy
- Need for alternative treatment strategies
Benefits of Taking the OncoPro TMB Test
Undergoing TMB testing provides numerous advantages for cancer patients and their healthcare providers:
- Personalized Treatment Planning: Identifies patients most likely to benefit from immunotherapy
- Improved Outcomes: Helps select the most effective treatment strategies
- Reduced Side Effects: Avoids ineffective treatments and their associated toxicities
- Comprehensive Analysis: Provides a holistic view of tumor genetics
- Clinical Trial Eligibility: May qualify patients for targeted clinical trials
- Cost-Effective Care: Directs resources toward treatments with higher success probability
Understanding Your Test Results
Your OncoPro TMB Test results will provide detailed information about your tumor’s genetic profile:
Interpretation Guidelines
- High TMB: Typically indicates increased likelihood of response to immunotherapy
- Intermediate TMB: May suggest moderate immunotherapy benefit
- Low TMB: Suggests limited response to current immunotherapies
It’s crucial to discuss your results with your oncologist, who will interpret them in the context of your specific cancer type, stage, and overall health status. Results should always be considered alongside other clinical factors and diagnostic information.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $1756 |
| Regular Price | $1950 |
Sample Requirements and Processing
Turnaround Time: Sample submission by Tuesday 11 AM; Results in 15 working days
Sample Type: Formalin-fixed paraffin-embedded (FFPE) tissue block
Requirements:
- FFPE block must contain at least 10% tumor tissue
- Ship at room temperature
- Provide copy of Histopathology report
- Complete NGS Test Requisition Form (Form 40)
Nationwide Availability
We have diagnostic centers across the United States, serving patients in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible, high-quality cancer genetic testing for patients nationwide.
Book Your Test Today
Take the next step in your cancer treatment journey with comprehensive genetic analysis. Our experienced team is ready to assist you with scheduling and answer any questions about the OncoPro TMB Test.
Call or WhatsApp: +1(267) 388-9828
Schedule your consultation today to determine if the OncoPro Tumor Mutation Burden Test is right for your treatment plan. Our genetic counselors and oncology specialists are available to provide guidance and support throughout the testing process.
